PLA2G7 Antikörper (AA 49-441) (FITC)

Produktnummer ABIN7163617

Produktdetails anti-PLA2G7 Antikörper (FITC)

Target: PLA2G7 (Lp-PLA2) (Lipoprotein-Associated phospholipase A2 (Lp-PLA2))

Bindungsspezifität: AA 49-441

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser PLA2G7 Antikörper ist konjugiert mit FITC

Applikation: Bitte anfragen

Kreuzreaktivität: Human

Aufreinigung: >95%, Protein G purified

Immunogen: Recombinant Human Platelet-activating factor acetylhydrolase protein (49-441AA)

Isotyp: IgG

Anwendungsinformationen

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C,-80 °C

Informationen zur Lagerung: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Details zu PLA2G7

Target: PLA2G7 (Lp-PLA2) (Lipoprotein-Associated phospholipase A2 (Lp-PLA2))

Andere Bezeichnung: PLA2G7 (Lp-PLA2 Produkte)

Synonyme: LDL-PLA2 antikoerper, LP-PLA2 antikoerper, PAFAD antikoerper, PAFAH antikoerper, Lp-PLA2 antikoerper, PAF-AH antikoerper, R75400 antikoerper, zgc:77563 antikoerper, phospholipase A2 group VII antikoerper, phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) antikoerper, PLA2G7 antikoerper, Pla2g7 antikoerper, pla2g7 antikoerper

Hintergrund:

Background: Modulates the action of platelet-activating factor (PAF) by hydrolyzing the sn-2 ester bond to yield the biologically inactive lyso-PAF. Has a specificity for substrates with a short residue at the sn-2 position. It is inactive against long-chain phospholipids.

Aliases: Platelet-activating factor acetylhydrolase precursor antibody, 1 alkyl 2 acetylglycerophosphocholine esterase antibody, 1-alkyl-2-acetylglycerophosphocholine esterase antibody, 2 acetyl 1 alkylglycerophosphocholine esterase antibody, 2-acetyl-1-alkylglycerophosphocholine esterase antibody, EC 3.1.1.47 PAF acetylhydrolase PAF 2-acylhydrolase LDL associated phospholipase A2 antibody, Group VIIA phospholipase A2 antibody, Group-VIIA phospholipase A2 antibody, gVIIA PLA2 antibody, gVIIA-PLA2 antibody, LDL associated phospholipase A2 antibody, LDL PLA(2) antibody, LDL PLA2 antibody, LDL-associated phospholipase A2 antibody, LDL-PLA(2) antibody, Lipoprotein associated phospholipase A2 antibody, LP PLA2 antibody, PAF 2 acylhydrolase antibody, PAF 2 acylhydrolase LDL associated phospholipase A2 antibody, PAF 2-acylhydrolase antibody, PAF acetylhydrolase antibody, PAFA_HUMAN antibody, PAFAD antibody, PAFAH antibody, Phospholipase A2, group VII (platelet activating factor acetylhydrolase, plasma) antibody, PLA2G7 antibody, Platelet activating factor acetylhydrolase 2 antibody, Platelet activating factor acetylhydrolase antibody, Platelet-activating factor acetylhydrolase antibody

UniProt: Q13093

Pathways: Peptide Hormone Metabolism